Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus

Neurogastroenterology and Motility

Volumn 22, Issue 3, 2010, Pages

  Li, Y Y ^a   Li, Y N ^a   Ni, J B ^a   Chen, C J ^a   Lv, S ^a   Chai, S Y ^a   Wu, R H ^a   Yuce B ^b   Storr, M ^c  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cannabinoid 1 receptor; Cannabinoid 2 receptor; Ileus; Intestinal myoelectrical activity; Lipopolysaccharide; Upper gastrointestinal transit

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CHARCOAL; DEXANABINOL; EOSIN; HEMATOXYLIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDING; GASTROINTESTINAL TRANSIT; HISTOLOGY; ILEUS; IN VIVO STUDY; INTESTINE MOTILITY; JEJUNUM; MALE; MOUSE; MYOELECTRICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SEPSIS; SEPTIC ILEUS; STAINING; STOMACH;

ANALYSIS OF VARIANCE; ANIMALS; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; ILEUS; INTERLEUKIN-6; JEJUNAL DISEASES; JEJUNUM; LIPOPOLYSACCHARIDES; MALE; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SEPSIS; TETRAHYDROCANNABINOL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76349103029     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2009.01419.x     Document Type: Article

References (46)

1. Gaoni Y, Mechoulam R. The isolation and structure of delta-1- tetrahydrocannabinol and other neutral cannabinoids from hashish. J Am Chem Soc 1971 93 : 217 224.
2. Devane WA, Hanus L, Breuer A et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992 258 : 1946 1949.
3. Howlett AC, Barth F, Bonner TI et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002 54 : 161 202.
4. Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut 2008 57 : 1140 1155.
5. Di Marzo V, Fontana A. Anandamide, an endogenous cannabinomimetic eicosanoid: 'killing two birds with one stone'. Prostaglandins Leukot Essent Fatty Acids 1995 53 : 1 11.
6. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990 346 : 561 564.
7. Izzo AA, Pinto L, Borrelli F, Capasso R, Mascolo N, Capasso F. Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil. Br J Pharmacol 2000 129 : 1627 1632.
8. Mang CF, Erbelding D, Kilbinger H. Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors. Br J Pharmacol 2001 134 : 161 167.
9. Storr M, Sharkey KA. The endocannabinoid system and gut-brain signalling. Curr Opin Pharmacol 2007 7 : 575 582.
10. Sanger GJ. Endocannabinoids and the gastrointestinal tract: what are the key questions? Br J Pharmacol 2007 152 : 663 670.
11. Martinez-Orgado J, Fernandez-Lopez D, Lizasoain I, Romero J. The seek of neuroprotection: introducing cannabinoids. Recent Pat CNS Drug Discov 2007 2 : 131 139.
12. Aviello G, Romano B, Izzo AA. Cannabinoids and gastrointestinal motility: animal and human studies. Eur Rev Med Pharmacol Sci 2008 12 (Suppl. 1 81 93.
13. Abalo R, Cabezos PA, Lopez-Miranda V et al. Selective lack of tolerance to delayed gastric emptying after daily administration of WIN 55,212-2 in the rat. Neurogastroenterol Motil 2009 21 : 1002 1013.
14. Di Marzo V, Capasso R, Matias I et al. The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet. Br J Pharmacol 2008 153 : 1272 1280.
15. Landi M, Croci T, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Manara L. Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors. Eur J Pharmacol 2002 450 : 77 83.
16. Storr M, Gaffal E, Saur D, Schusdziarra V, Allescher HD. Effect of cannabinoids on neural transmission in rat gastric fundus. Can J Physiol Pharmacol 2002 80 : 67 76. (Pubitemid 34194288)
17. Storr MA, Yuce B, Andrews CN, Sharkey KA. The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome. Neurogastroenterol Motil 2008 20 : 857 868.
18. Duncan M, Mouihate A, Mackie K et al. Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats. Am J Physiol Gastrointest Liver Physiol 2008 295 : G78 87.
19. Wright KL, Duncan M, Sharkey KA. Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br J Pharmacol 2008 153 : 263 270.
20. Mathison R, Ho W, Pittman QJ, Davison JS, Sharkey KA. Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats. Br J Pharmacol 2004 142 : 1247 1254.
21. Coutts AA, Izzo AA. The gastrointestinal pharmacology of cannabinoids: an update. Curr Opin Pharmacol 2004 4 : 572 579.
22. D'Argenio G, Petrosino S, Gianfrani C et al. Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats. J Mol Med 2007 85 : 523 530.
23. Mascolo N, Izzo AA, Ligresti A et al. The endocannabinoid system and the molecular basis of paralytic ileus in mice. FASEB J 2002 16 : 1973 1975.
24. Massa F, Marsicano G, Hermann H et al. The endogenous cannabinoid system protects against colonic inflammation. J Clin Invest 2004 113 : 1202 1209.
25. Izzo AA, Mascolo N, Borrelli F, Capasso F. Defaecation, intestinal fluid accumulation and motility in rodents: implications of cannabinoid CB1 receptors. Naunyn Schmiedebergs Arch Pharmacol 1999 359 : 65 70.
26. De Filippis D, Iuvone T, D'Amico A et al. Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase. Neurogastroenterol Motil 2008 20 : 919 927.
27. Li YY, Sibaev A, Zhou MZ, Zhu GY, Yuce B, Storr M. The Chinese herbal preparation Qing Yi Tang (QYT) improves intestinal myoelectrical activity and increases intestinal transit during acute pancreatitis in rodents. Phytother Res 2007 21 : 324 331.
28. Yuce B, Sibaev A, Broedl U et al. Cannabinoid type 1 receptor modulates intestinal propulsion by an attenuation of intestinal motor responses within the myenteric part of the peristaltic reflex. Neurogastroenterol Motil 2007 19 : 744 753.
29. Lu G, Qian X, Berezin I, Telford GL, Huizinga JD, Sarna SK. Inflammation modulates in vitro colonic myoelectric and contractile activity and interstitial cells of Cajal. Am J Physiol 1997 273 : G1233 45.
30. Storr M, Sibaev A, Weiser D et al. Herbal extracts modulate the amplitude and frequency of slow waves of circular smooth muscle of mouse small intestine. Digestion 2004 70 : 257 264.
31. Tanabe Y, Calland JF, Schirmer BD. Effects of peritoneal injury and endotoxin on myoelectric activity and transit. J Surg Res 2004 116 : 330 336.
32. Guerrero-Lindner E, Castro M, Munoz JM et al. Central tumour necrosis factor-alpha mediates the early gastrointestinal motor disturbances induced by lipopolysaccharide in sheep. Neurogastroenterol Motil 2003 15 : 307 316.
33. Wechsung E. The involvement of prostaglandins in the inhibiting effect of endotoxin on the myoelectric activity of the gastrointestinal system in pigs. Verh K Acad Geneeskd Belg 1996 58 : 711 738.
34. Capasso R, Borrelli F, Cascio MG et al. Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors. Br J Pharmacol 2008 155 : 681 689.
35. Izzo AA, Fezza F, Capasso R et al. Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. Br J Pharmacol 2001 134 : 563 570.
36. Izzo AA, Mascolo N, Pinto L, Capasso R, Capasso F. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats. Eur J Pharmacol 1999 384 : 37 42.
37. Schwarz NT, Engel B, Eskandari MK, Kalff JC, Grandis JR, Bauer AJ. Lipopolysaccharide preconditioning and cross-tolerance: the induction of protective mechanisms for rat intestinal ileus. Gastroenterology 2002 123 : 586 598.
38. De Winter BY, Bredenoord AJ, Van Nassauw L et al. Involvement of afferent neurons in the pathogenesis of endotoxin-induced ileus in mice: role of CGRP and TRPV1 receptors. Eur J Pharmacol 2009 615 : 177 184.
39. Theodorou V, Chovet M, Eutamene H et al. Antidiarrhoeal properties of a novel sigma ligand (JO 2871) on toxigenic diarrhoea in mice: mechanisms of action. Gut 2002 51 : 522 528.
40. Murai M, Tsuji F, Nose M et al. SA13353 (1-[2-(1-Adamantyl)ethyl]-1- pentyl-3-[3-(4-pyridyl)propyl]urea) inhibits TNF-alpha production through the activation of capsaicin-sensitive afferent neurons mediated via transient receptor potential vanilloid 1 in vivo. Eur J Pharmacol 2008 588 : 309 315.
41. De Winter BY, Van Nassauw L, De Man JG et al. Role of oxidative stress in the pathogenesis of septic ileus in mice. Neurogastroenterol Motil 2005 17 : 251 261.
42. Kudo H, Takahara T, Yata Y, Kawai K, Zhang W, Sugiyama T. Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model. J Hepatol 2009 51 : 168 175.
43. Desai A, Konda VR, Darland G et al. META060 inhibits multiple kinases in the NF-kappaB pathway and suppresses LPS-mediated inflammation in vitro and ex vivo. Inflamm Res 2009 58 : 229 234.
44. Hellstrom PM, al Saffar A, Ljung T, Theodorsson E. Endotoxin actions on myoelectric activity, transit, and neuropeptides in the gut. Role of nitric oxide. Dig Dis Sci 1997 42 : 1640 1651.
45. Hara S, Nemoto K, Ninomiya N, Kubota M, Kuno M, Yamamoto Y. Continuous infusion of sivelestat sodium hydrate prevents lipopolysaccharide-induced intestinal paralysis and hypotension in conscious guinea-pigs. Clin Exp Pharmacol Physiol 2008 35 : 841 845.
46. McVey DC, Schmid PC, Schmid HH, Vigna SR. Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1). J Pharmacol Exp Ther 2003 304 : 713 722.